CANCER HOSPITAL, CHINESE ACADEMY OF MEDICAL SCIENCES

CANCER HOSPITAL, CHINESE ACADEMY OF MEDICAL SCIENCES specializes in advanced clinical research and translational science, with a demonstrated focus on nutrition intervention trials and biobanking for oncology applications. Their core capabilities center on designing and executing complex biomedical research protocols, including sample collection, storage, and longitudinal data management within controlled clinical environments. The organization leverages deep expertise in bio-specimen handling, ethical compliance for human subject research, and integrated data systems to support precision medicine initiatives. Their work bridges clinical oncology with nutritional science, applying evidence-based methodologies to evaluate dietary impacts on cancer outcomes, positioning them as a specialized research entity within the broader medical research ecosystem. The contractor has delivered services under the U.S. Department of Health and Human Services, primarily supporting public health research initiatives involving clinical trial infrastructure and biological specimen banking. This reflects a focused engagement with federal health research programs that require rigorous scientific methodology and regulatory alignment with human subject protections. Their primary industry focus is in professional, scientific, and technical services, specifically in the domain of biomedical research support. This includes clinical trial management, biorepository operations, and data collection systems tailored to cancer epidemiology and nutritional biomarker analysis. The organization is positioned as a niche provider of high-integrity research services within the global oncology research community. As a non-U.S. entity based in Beijing, the organization operates under its institutional structure without U.S. government certifications. Its geographic presence is anchored in China, with its government market positioning centered on international collaborative research partnerships rather than direct domestic U.S. contracting. Award history indicates limited but highly specialized engagement in federally funded biomedical research projects.